Endpoints News 生物医药· Anna Brown·· 9 天前AI 评分35
VectorY 获 8350 万美元融资推进神经退行性疾病抗体基因疗法
VectorY bags $83.5M for antibody gene therapies in neurodegenerative diseases
AI 导读
VectorY 获得 8350 万美元融资,用于开发可在脑内生产抗体的基因疗法,针对神经退行性疾病。
正文
VectorY Therapeutics added €74.5 million ($83.5 million) to its Series A to fund a gene therapy that makes antibodies in the brain.
The biotech’s lead …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news